Micro-cap frenzy proves a money spinner
How an upstart corporate advisory firm is rapidly listing companies at the micro-cap end of the market, and how its network of friends and family are raking it in along the way.
Jemima Whyte writes on business, specialising in companies, capital markets and innovation. Jemima has reported on business for The Australian Financial Review for more than 13 years.
How an upstart corporate advisory firm is rapidly listing companies at the micro-cap end of the market, and how its network of friends and family are raking it in along the way.
Australia's top 50 private givers are all generous, but what they want in return varies greatly. Some give with no strings attached; others have higher expectations.
Bullish tweets about a lithium stock have caught the market operator's attention.
Timing will be everything for Jetstar's new chief Gareth Evans – including delivering on market expectations that he is well-placed to succeed Qantas chief Alan Joyce.
Updater, a $560 million New York-based company, is reaching its moment of truth.
How an Australian animal rights activist and award-winning photographer followed a trail of corruption that went to the very top of the Zimb...
What's legal and what's not in the murky world of ivory trading.
Lawyers Corrs Chambers Westgarth have filed a second class action against GetSwift.
Listed investment company Chapmans is seeking to raise up to $7.3 million to invest in a Canadian crypto-mining and data processing company.
A tussle for control of a small pot stock underscores the potential conflict of interest for small corporate advisers, which hold shareholdi...
The $300 million class action against GetSwift has broadened its statement of claim, including contract announcements with Amazon, YUM Brand...
When it bought Coles in 2008 it was the biggest takeover in Australian corporate history. Now Wesfarmers is cutting it free. Was the journey...
Medical imaging group Capitol Health has gone out swinging after conceding its attempt to buy larger rival Integral Diagnostic for $300 mill...
The latest class action brought against Standard & Poor's for its rating of CDOs has the potential to open the floodgates for more cases.
Alan Joyce will stick to his knitting running the airline when politicians figure out again how to knit.
Wattle Health has defied critics with its share price increasing by 12 times in the past year. But what will it take to keep going?
The corporate regulator has served GetSwift with a notice to produce documents, the company said, as it reported a jump in interim revenue t...
Assad Tannous, the founder of Asenna Wealth, has sold shares in Creso Pharma.
Capitol Health has flagged it is unlikely to extend its $300 million bid for rival Integral Diagnostics beyond March.
GetSwift has severed ties with Aesir Capital, the broker which advised the last mile logistics provider on the $75 million capital raise at ...
More
Enjoy unlimited access to Australia's best business news and market insights across desktop, tablet and mobile
Already a subscriber? Log in